Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People 55 and older represent 41% of the U.S. population living with HIV. Learn more about #HIVandAging and #NHAAD.
Research on the links between tenofovir and other antiretrovirals, SARS-CoV-2 infection and COVID severity has produced mixed results.
There are now three FDA-approved PrEP medications in the United States—two are pills, and one is a shot.
The USPSTF’s latest recommendation could make long-acting PrEP (Apretude) more accessible—if a looming court case doesn’t interfere.
#SHAAD is Sunday, August 20. In 2021, the South comprised 38% of the U.S. population but 52% of new HIV diagnoses. Here’s why.
The American Red Cross started screening all donors using a questionnaire to evaluate behavior-based risk. Folks on PrEP may not donate.
At three years, median height and bone mineral density were similar for children with and without tenofovir exposure in the womb.
Emergency rooms can provide vital access to HIV services. Just ask the Swedish Ballard Emergency Department in King County, Washington.
PrEP4All’s advocacy for a National PrEP Program to prevent HIV gets a $670,000 boost from the Elton John AIDS Foundation.
The proposal improves on current Medicare coverage, which allows cost-sharing fees and mostly excludes long-acting PrEP.
The $3.6 billion antitrust court case cleared Gilead Sciences and Teva of delaying the release of generic Truvada and other HIV meds.
Ending the mandate to cover preventive care such as PrEP “will cause incalculable harm to our efforts to end the HIV epidemic.”
Daily dosing or long-acting injectables may be better options for those who have spontaneous sex.
A jury in May ruled in favor of Gilead Sciences, maker of HIV prevention pills. Now the government wants a judge to overturn the verdict.
The LGBTQ group Human Rights Campaign Foundation joins HIV organizations to get the word out that Undetectable Equals Untransmittable.
New agreement ensures coverage of prevention services for now, a move applauded by patient groups for those with cancer, HIV and more.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.